Develops prepaid cards for pharmaceutical payments and clinical trials.
Jun 2026Revenue $101M/yrExpenses $83.5M/yr
No trend
Figures by year
Is Paysign profitable?
Yes. In the 12 months to Jun 2026, revenue was $101M and expenses $83.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $82.0M | $74.7M | $7.36M |
| Dec 2024 | $58.4M | $57.4M | $1.02M |
| Dec 2023 | $47.3M | $47.4M | −$167K |
| Dec 2022 | $38.0M | $37.7M | $344K |
| Dec 2021 | $29.5M | $32.2M | −$2.74M |
| Dec 2020 | $24.1M | $32.5M | −$8.34M |
| Dec 2019 | $34.7M | $28.6M | $6.10M |
| Dec 2018 | $23.4M | $21.0M | $2.47M |
| Dec 2017 | $15.2M | $13.5M | $1.77M |
| Dec 2016 | $10.4M | $9.06M | $1.36M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.